Vogt-Koyanagi Harada Disease in Pediatric Age
Keywords:
Vogt-Koyanagi-Harada, children, complicationsAbstract
Vogt-Koyanagi-Harada syndrome, originally known as uveomeningitic syndrome, is a chronic multisystem autoimmune disease characterized by bilateral granulomatous panuveitis with exudative retinal detachment and papillitis. It affects melanocyte-rich tissues such as the eye, inner ear, meninges, skin and hair. A 10-year-old male patient presents with ocular pain and decreased vision in both eyes. Biomicroscopy of the anterior segment showed graying of the eyebrows, moderate cilio-conjunctival injection, mild corneal edema, keratic precipitates in mutton fat, 3+ cellularity in anterior chamber, iris transillumination in periphery, posterior synechiae in 360 degrees in right eye and opacity of the lens in both eyes. In the general physical examination, graying of the hair and hypopigmented spots in different parts of the body were observed. Treatment was based on the suppression of intraocular inflammation with early and prolonged use of systemic corticosteroids and immunomodulators, in addition to the surgical treatments performed to treat the existing ocular complications. The presentation of this case reaffirms the importance of a quick and accurate diagnosis, in spite of being an infrequent disease in this age, it shows that it is necessary to know it in order to treat the complications and avoid irreversible sequelae such as blindness at such early ages of life when in the presence of a similar clinical picture.
Downloads
References
1. Pabón Páramo CA, Noboa Jiménez AM, Orias Durán JM. Enfermedad de Vogt-Koyanagi-Harada. Revista Médica Sinergia. 2020 [acceso 22/09/2022];5(1). Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/338/688
2. Vilches Lescaille D, Miranda Hernández T, Ambou Frutos I. Síndrome Vogt-Koyanagi-Harada. En: Colectivo de autores. Manual de diagnóstico y tratamiento en Oftalmología. 2da ed. La Habana: Editorial Ciencias Médicas; 2019.
3. Betancourt R, Betancourt SA, Soler G, Mantilla RD, Castillo GA. Enfermedad de Vogt Koyanagi Harada. Reporte de un caso y revisión de la literatura. Rev Colomb Reumatol. 2020;27(1):50-60. DOI: 10.1016/j.rcreu.2018.12.002
4. Rincón M, Valenzuela DJ, Endo B, Castro A. Enfermedad de Vogt-Koyanagi Harada en población pediátrica: reporte de casos y revisión de la literatura. Rev SCO. 2018 [acceso 22/09/2022];51(2):174-80. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=7025768
5. Du L, Kijlstra A, Yang P. Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment. Prog Retin Eye Res. 2016;52:84-111. DOI: 10.1016/j.preteyeres.2016.02.002.
6. Takada S, Tanaka R, Kurita N, Koshi, K. Vogt-Koyanagi-Harada disease in 3-year-old boy: Recursos Electrónicos (Bases de Datos y Catálogo Biblos). Clinical and experimental Ophthalmology. 2015 [acceso 22/09/2022];593-4. Disponible en: https://n9.cl/7l0y00
7. Herbort CP, Abu El Asrar AM, Takeuchi M, Pavésio CE, Couto C, Hedayatfar A, et al. Catching the therapeutic window of opportunity in early initial-onset Vogt-Koyanagi-Harada uveitis can cure the disease. International Ophthalmology. 2019;39(6):1419–25. DOI: 10.1007/s10792-018-0949-4
8. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. American Journal of Ophthalmology. 2001;131(5):647–52. DOI: 10.1016/s0002-9394(01)00925-4
9. Pan D, Hirose T. Vogt-Koyanagi-Harada Syndrome: Review of Clinical Features. Seminars in Ophthalmology. 2011;26(4-5):312–315. DOI: 10.3109/08820538.2011.588654
10. Patil Y, Garg R, Rajguru J, Sirsalmath M, Bevinakatti V, Kumar M, et al. Vogt–Koyanagi–Harada (VKH) syndrome: A new perspective for healthcare professionals. Journal of Family Medicine and Primary Care. 2020;9(1):31-5. DOI: 10.4103/jfmpc.jfmpc_787_19
11. Guido J, Félix C, Lorena M, Álvaro V, Martín G, Ricardo S. Literature review on Vogt-Koyanagi-Harada disease: An infrequent entity with effective treatment. Rev. Ecuat. Neurol. 2023;32(3). DOI: 10.46997/revecuatneurol32300052
12. Gao F, Zhao C, Cheng G, Pei M, Liu X, Wang M, et al. Clinical Patterns of Uveitis in a Tertiary Center in North China. Ocular Immunology and Inflammation. 2017;25:1–7.DOI: 10.3109/092739 48.2016.1158279
13. Albaroudi N, Tijani M, Boutimzine N, Cherkaoui O. Clinical and therapeutic features of pediatric Vogt-Koyanagi-Harada disease. Journal Français d’Ophtalmologie. 2020;43(5):427–32. DOI: 10.1016/j.jfo.2019.10.005
14. Rahman N, Artiaga JCM, Bouras K, Luis J, Rees A, Westcott M. Immunosuppressive therapy for VogtKoyanagi-Harada disease: a retrospective study and review of literature. J Ophthal Inflamm Infect. 2023;13(1):27. DOI: 10.1186/s12348-023-00333-6
15. Berker N, Ozdamar Y, Soykan E, Ozdal P, Ozkan SS. Vogt- Koyanagi-Harada syndrome in children: Report of a case and review of the literature. Ocul. Immunol. Inflamm. 15, 351- 357 (2007). DOI: 10.1080/09273940701459453
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Revista Cubana de Oftalmología

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
El contenido de la revista se encuentra accesible sin costo alguno. Está protegido por los términos de la Licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional